SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-04-02 10:10
Tx date 2024-03-31
$MDA
MDA Ltd.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights

+887 vol
887
Filed 2024-04-02 10:09
Tx date 2024-02-14
$MDA
MDA Ltd.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2024-01-13 16:04
Tx date 2024-01-11
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$14,267
+13,334 vol
$1.07 each
333,334
Filed 2024-01-13 16:03
Tx date 2024-01-11
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-14,267.38
-13,334 vol
$1.07 each
1,666
Filed 2023-11-18 15:20
Tx date 2023-11-15
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$1,733
+1,667 vol
$1.04 each
320,000
Filed 2023-11-18 15:19
Tx date 2023-11-15
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-1,733.68
-1,667 vol
$1.04 each
15,000
Filed 2023-09-15 18:24
Tx date 2023-09-12
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+15,000 vol
40,000
Filed 2023-01-14 15:54
Tx date 2023-01-11
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$7,866
+13,333 vol
$0.59 each
318,333
Filed 2023-01-14 15:53
Tx date 2023-01-11
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-7,866.47
-13,333 vol
$0.59 each
16,667
Filed 2022-12-01 22:19
Tx date 2022-11-28
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$2,560
+5,334 vol
$0.48 each
305,000
Filed 2022-12-01 22:18
Tx date 2022-11-28
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-2,560.32
-5,334 vol
$0.48 each
30,000
Filed 2022-11-19 12:58
Tx date 2022-11-15
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$800.16
+1,667 vol
$0.48 each
299,666
Filed 2022-11-19 12:57
Tx date 2022-11-15
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-800.16
-1,667 vol
$0.48 each
35,334
Filed 2022-11-19 12:55
Tx date 2022-11-15
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+5,000 vol
25,000
Filed 2022-01-13 13:56
Tx date 2022-01-11
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+13,333 vol
297,999
Filed 2022-01-13 13:53
Tx date 2022-01-11
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-13,333 vol
37,001
Filed 2021-12-01 23:39
Tx date 2021-11-29
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+5,333 vol
284,666
Filed 2021-12-01 23:38
Tx date 2021-11-29
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-5,333 vol
50,334
Filed 2021-11-19 20:24
Tx date 2021-11-15
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+5,000 vol
55,667
Filed 2021-11-03 16:59
Tx date 2021-11-01
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$23,265
+23,500 vol
$0.99 each
279,333
Filed 2021-11-03 16:58
Tx date 2021-11-01
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,430
+3,500 vol
$0.98 each
255,833
Filed 2021-11-03 16:58
Tx date 2021-11-01
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$960.00
+1,000 vol
$0.96 each
252,333
Filed 2021-11-03 16:57
Tx date 2021-11-01
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,175
+6,500 vol
$0.95 each
251,333
Filed 2021-11-03 16:56
Tx date 2021-11-01
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$19,740
+21,000 vol
$0.94 each
244,833
Filed 2021-11-03 16:55
Tx date 2021-11-01
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,650
+5,000 vol
$0.93 each
223,833
Filed 2021-11-03 16:55
Tx date 2021-11-01
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,275
+2,500 vol
$0.91 each
218,833
Filed 2021-11-03 16:54
Tx date 2021-11-01
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$22,250
+25,000 vol
$0.89 each
216,333
Filed 2021-10-13 17:19
Tx date 2021-10-04
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+12,000 vol
191,333
Filed 2021-10-13 17:18
Tx date 2021-10-04
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-12,000 vol
50,667
Filed 2021-01-15 19:01
Tx date 2021-01-11
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+40,000 vol
62,667
Filed 2020-12-17 18:50
Tx date 2020-12-01
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
37 - Stock split or consolidation

-204,000 vol
22,667
Filed 2020-12-17 18:49
Tx date 2020-12-01
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-180,000 vol
20,000
Filed 2020-12-17 18:48
Tx date 2020-12-01
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-2,160,000 vol
240,000
Filed 2020-12-17 18:47
Tx date 2020-12-01
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-1,614,000 vol
179,333
Filed 2020-12-17 14:50
Tx date 2020-11-30
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+53,333 vol
1,793,333
Filed 2020-12-17 14:49
Tx date 2020-11-30
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-53,333 vol
226,667
Filed 2020-10-08 22:45
Tx date 2020-10-05
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+120,000 vol
1,740,000
Filed 2020-10-08 22:43
Tx date 2020-10-05
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-120,000 vol
280,000
Filed 2020-06-06 14:41
Tx date 2020-06-05
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
Common Shares
54 - Exercise of warrants
$75,000
+500,000 vol
$0.15 each
2,400,000
Filed 2020-06-06 14:40
Tx date 2020-06-05
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
Warrants
54 - Exercise of warrants
$-75,000
-500,000 vol
$0.15 each
0
Filed 2019-11-28 13:16
Tx date 2019-11-28
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+160,000 vol
400,000
Filed 2019-10-10 16:06
Tx date 2019-10-03
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+120,000 vol
1,620,000
Filed 2019-10-10 16:05
Tx date 2019-10-03
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-120,000 vol
240,000
Filed 2018-12-13
Tx date 2018-12-13
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
Common Shares
54 - Exercise of warrants
$66,000
+300,000 vol
$0.22 each
1,900,000
Filed 2018-12-13
Tx date 2018-12-13
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
Warrants
54 - Exercise of warrants
$-66,000
-300,000 vol
$0.22 each
500,000
Filed 2018-10-05
Tx date 2018-10-03
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
97 - Other

+360,000 vol
360,000
Filed 2018-10-05
Tx date 2016-07-18
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2018-06-10
Tx date 2018-06-05
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$-75,000
-500,000 vol
$0.15 each
0
Filed 2018-06-10
Tx date 2018-06-05
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$75,000
+500,000 vol
$0.15 each
1,500,000
Filed 2017-09-12
Tx date 2016-07-18
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-08
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Holder: Raging Boar Enterprises (Indirect Ownership)
Common Shares
90 - Change in the nature of ownership

-1,000,000 vol
0
Filed 2017-09-12
Tx date 2016-07-18
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-08
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership

+1,000,000 vol
1,000,000
Filed 2017-09-12
Tx date 2017-09-08
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Holder: Raging Boar Enterprises (Indirect Ownership)
Warrants
90 - Change in the nature of ownership

-500,000 vol
0
Filed 2017-09-12
Tx date 2017-09-08
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Warrants
90 - Change in the nature of ownership

+500,000 vol
500,000
Filed 2017-08-21
Tx date 2017-08-18
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
Warrants
15 - Acquisition or disposition under a prospectus
$50,000
+500,000 vol
$0.10 each
800,000
Filed 2017-08-21
Tx date 2017-08-18
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
Common Shares
15 - Acquisition or disposition under a prospectus
$100,000
+1,000,000 vol
$0.10 each
1,600,000
Filed 2017-07-19
Tx date 2017-07-11
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+600,000 vol
600,000
Filed 2017-07-19
Tx date 2016-07-18
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-07-19
Tx date 2017-07-18
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
Warrants
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+300,000 vol
300,000
Filed 2017-07-19
Tx date 2016-07-18
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2017-04-03
Tx date 2016-07-18
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-04-03
Tx date 2017-03-31
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$40,000
+200,000 vol
$0.20 each
200,000
Filed 2016-07-21
Tx date 2016-07-18
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Holder: Raging Boar Enterprises (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
500,000
Filed 2016-07-21
Tx date 2016-07-18
$ATE
Antibe Therapeutics Inc.
Wu, Yung Cheng
4 - Director of Issuer
Holder: Raging Boar Enterprises (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
1,000,000